Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Immuron Ltd Regulatory Filings 2017

Jun 6, 2017

35121_rns_2017-06-06_181a25ed-c679-403a-a978-eefd4dbdc030.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm

IMMURON LIMITED

Suite 1, 1233 High Street

Armadale, Victoria, Australia 3143

June 6, 2017

Securities and Exchange Commission
Division of Corporate Finance
100 F Street, NE
Washington, DC 20549
Attn: Suzanne Hayes, Esq.
Assistant Director
Re: Immuron Limited
Registration Statement on Form F-1
File No. 333-215204 (the “Registration
Statement”)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 5:00 P.M. EDT on June 7, 2017, or as soon thereafter as is practicable.

Should you have any questions regarding the foregoing, please do not hesitate to contact our counsel Darrin Ocasio, Esq. of Sichenzia Ross Ference Kesner LLP at (212) 930-9700.

| Very
truly yours, | |
| --- | --- |
| IMMURON
LIMITED | |
| By: | /s/
Thomas Liquard |
| | Thomas Liquard, Chief Executive Officer |